Definium Therapeutics, Inc. (DFTX)
NASDAQ: DFTX · Real-Time Price · USD
43.27
-1.64 (-3.65%)
At close: Aug 24, 2026, 4:00 PM EDT
43.25
-0.02 (-0.05%)
After-hours: Aug 24, 2026, 7:56 PM EDT
Definium Therapeutics Employees
As of December 31, 2025, Definium Therapeutics had 106 total employees, including 105 full-time and 1 part-time employees. The number of employees increased by 32 or 43.24% compared to the previous year.
Employees
106
Change (1Y)
32
Growth (1Y)
43.24%
Revenue / Employee
n/a
Profits / Employee
-$3,337,594
Market Cap
5.81B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 106 | 32 | 43.24% | 105 | 1 |
| Dec 31, 2024 | 74 | 17 | 29.82% | 74 | 0 |
| Dec 31, 2023 | 57 | 9 | 18.75% | 57 | 0 |
| Dec 31, 2022 | 48 | 7 | 17.07% | 48 | 0 |
| Dec 31, 2021 | 41 | 19 | 86.36% | 41 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| PTC Therapeutics | 991 |
| ACADIA Pharmaceuticals | 798 |
| Travere Therapeutics | 497 |
| Mirum Pharmaceuticals | 433 |
| CRISPR Therapeutics AG | 393 |
| Xenon Pharmaceuticals | 370 |
| Cogent Biosciences | 258 |
| Erasca | 103 |
DFTX News
- 7 days ago - Definium Therapeutics initiated with a Buy at BofA - TheFly
- 7 days ago - Definium Therapeutics Announces New Employee Inducement Grants - Business Wire
- 7 days ago - Definium Therapeutics announces results from Phase 3 study of DT120 - TheFly
- 7 days ago - Definium Therapeutics price target raised to $70 from $60 at Oppenheimer - TheFly
- 7 days ago - Definium Therapeutics price target raised to $66 from $50 at Needham - TheFly
- 7 days ago - RBC Capital boosts Definium price target, says opportunity will be robust - TheFly
- 7 days ago - Definium Therapeutics price target raised to $75 from $57 at Baird - TheFly
- 7 days ago - Definium Therapeutics price target raised to $64 from $58 at Canaccord - TheFly